RSSCategory: Pharmaceuticals

Eye injection Aflibercept proves effective in Polypoidal Choroidal Vasculopathy (PCV), common in Asia Pacific

December 11, 2017
Eye injection Aflibercept proves effective in Polypoidal Choroidal Vasculopathy (PCV), common in Asia Pacific

Pharmaceutical and life sciences company Bayer recently announced that its anti-VEGF treatment aflibercept solution for injection into the eye is effective as monotherapy in patients who have Polypoidal Choroidal Vasculopathy (PCV). PCV is a subtype of wet age-related macular degeneration (wet AMD) that is particularly prevalent in Asia Pacific. Wet AMD is a leading cause [...]

Continue Reading

200 drugs in race to beat cancer

December 8, 2017
200 drugs in race to beat cancer

The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. The result is a scramble for patients to enrol in clinical trials, duplication of effort and the likely ultimate failure of many projects, according to experts. [...]

Continue Reading

Top natural antihistamines

October 25, 2017
Top natural antihistamines

Histamine is a protein that causes all of the symptoms you associate with allergies — the sneezing and cold-like symptoms you despise. Antihistamines block histamine activity, seeking to stop the allergic reaction. The following are 3 natural antihistamines: 1.    Vitamin C Vitamin C is an easy-to-find natural antihistamine. It’s prevalent in many fruits and vegetables, [...]

Continue Reading

Three in ten adults with type 2 diabetes resist insulin therapy

October 6, 2017
Three in ten adults with type 2 diabetes resist insulin therapy

Three in ten adults with type 2 diabetes resist the much-needed insulin therapy, a study has found. On average, these patients delay insulin for about two years, researchers report in Diabetic Medicine. “This matters to patients because insulin therapy is typically offered to patients with high blood sugar levels,” said senior study author Dr. Alexander [...]

Continue Reading

New drugs specifically designed to treat migraine currently in the pipeline

September 25, 2017
New drugs specifically designed to treat migraine currently in the pipeline

Migraine is listed by the World Health Organization (WHO) as the third most prevalent illness in the world, behind only tooth decay and tension-type headaches. It affects over 38 million Americans, including approximately 28 million women, who are afflicted at a rate three times that of men. But despite its prevalence, migraine — the condition [...]

Continue Reading

WHO calls on SEA nations to cooperate to make drugs, treatment accessible

September 11, 2017
WHO calls on SEA nations to cooperate to make drugs, treatment accessible

The World Health Organization (WHO) has called on Southeast Asian countries to work together to make medical treatment and drugs more affordable for the citizens. The countries were asked to take bold action ensuring citizens access to safe efficacious, quality and affordable medical products. The WHO also wants more emphasis to be given on leveraging [...]

Continue Reading

Novartis makes history with US approval of first “living drug” cancer therapy

September 4, 2017
Novartis makes history with US approval of first “living drug” cancer therapy

Swiss multinational pharmaceutical company Novartis made history as the US Food and Drug Administration (FDA) approved its tailor-made “living drug” therapy against cancer. Dubbed “CAR-T”, the treatment is the first to redesign a patient’s own immune system so it attacks cancer. The drug is tailor-made to each patient, unlike conventional therapies such as surgery or [...]

Continue Reading

Drug combination found to be highly effective against heart diseases

August 28, 2017
Drug combination found to be highly effective against heart diseases

Scientists in a major international study has found that the combination of two drugs – rivaroxaban and aspirin – is more effective in preventing further heart complications in people with cardiovascular diseases (CVDs) as compared to only aspirin or only rivaroxaban. Rivaroxaban, often known by the brand name Xarelto, is an anticoagulant, aspirin is an [...]

Continue Reading

Scientists use plants in new polio vaccine breakthrough

August 16, 2017
Scientists use plants in new polio vaccine breakthrough

The world may have taken a step towards a polio-free future as researchers make a breakthrough in vaccine development against the disease. An international consortium of scientists at the John Innes Centre in Norwich, UK was able to produce a new poliovirus vaccine by growing virus-like particles (VLPs), which are non-pathogenic mimics of the virus, [...]

Continue Reading

Hepatitis drugs are becoming more affordable

July 31, 2017
Hepatitis drugs are becoming more affordable

Drugs therapies to cure hepatitis C and treat hepatitis B are becoming more affordable as prices are dropping dramatically, giving hope to 325 million people living with the viral liver disease that can be fatal, the World Health Organization (WHO) said. A generic antiviral drug for hepatitis C, which can be cured in three months, [...]

Continue Reading